Quadrant Capital Group’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-100
Closed -$1.15K 2159
2026
Q1
$1.15K Hold
100
﹤0.01% 2573
2025
Q4
$1.44K Hold
100
﹤0.01% 2558
2025
Q3
$1.89K Buy
+100
New +$1.65K ﹤0.01% 2474
2025
Q2
Sell
-100
Closed -$1.31K 2208
2025
Q1
$1.31K Hold
100
﹤0.01% 2566
2024
Q4
$1.34K Sell
100
-60
-38% -$966 ﹤0.01% 2549
2024
Q3
$3.39K Buy
160
+60
+60% +$1.08K ﹤0.01% 2396
2024
Q2
$1.58K Hold
100
﹤0.01% 2511
2024
Q1
$1.49K Hold
100
﹤0.01% 2548
2023
Q4
$915 Hold
100
﹤0.01% 2568
2023
Q3
$557 Hold
100
﹤0.01% 2556
2023
Q2
$806 Hold
100
﹤0.01% 2522
2023
Q1
$654 Hold
100
﹤0.01% 2572
2022
Q4
$246 Buy
+100
New +$313 ﹤0.01% 2687

Other funds holding OSCR

Quadrant Capital Group's OSCR Position: Q2 2026 in Review

Quadrant Capital Group sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 100 shares — an estimated $1.15K sold.

Quadrant Capital Group first reported a position in OSCR in Q4 2022 and held it in 13 quarters. The position peaked at $3.39K in Q3 2024. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Quadrant Capital Group reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 100 Oscar Health shares in Q2 2026, an estimated $1.15K.
  • Quadrant Capital Group first reported a position in Oscar Health in Q4 2022 and held it in 13 quarters.
  • Quadrant Capital Group's Oscar Health position peaked at $3.39K in Q3 2024.
  • 402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.